☆
4.7
Article
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Rate this paper
The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search